Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study. - Wikidata - thesis-toulmin - TriplyDB

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.

http://www.wikidata.org/entity/Q30389929

about

Epidemic potential of Escherichia coli ST131 and Klebsiella pneumoniae ST258: a systematic review and meta-analysis Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain.CTX-M Enzymes: Origin and Diffusion.Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.Antibiotic resistance genes in the bacteriophage DNA fraction of environmental samples.Escherichia coli ST131, an intriguing clonal group Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance.Molecular characterization of multiresistant Escherichia coli producing or not extended-spectrum β-lactamases.Contribution of IncFII and broad-host IncA/C and IncN plasmids to the local expansion and diversification of phylogroup B2 Escherichia coli ST131 clones carrying blaCTX-M-15 and qnrS1 genes A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics.Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retros Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes.Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?Detection of quinolone-resistant Escherichia coli isolates belonging to clonal groups O25b:H4-B2-ST131 and O25b:H4-D-ST69 in raw sewage and river water in Barcelona, Spain.Evolving beta-lactamase epidemiology in Enterobacteriaceae from Italian nationwide surveillance, October 2013: KPC-carbapenemase spreading among outpatients.Analysis of blaSHV-12-carrying Escherichia coli clones and plasmids from human, animal and food sources.CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection of Escherichia coli isolates with characterized resistance phenotypes.Antibiotic resistance genes in the bacteriophage DNA fraction of human fecal samples.Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain.What do Spaniards read about the prudent use of anti-microbial agents and what do they really do?Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.Novel sequence types of extended-spectrum and acquired AmpC beta-lactamase producing Escherichia coli and Escherichia clade V isolated from wild mammals.β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.Nationwide study of Escherichia coli producing extended-spectrum β-lactamases TEM, SHV and CTX-M in Turkey.

P2860

Q28073332-11360A1C-0198-47CA-8F7B-83E78A468E25 Q30396308-9B24C0E5-97F1-46BC-AE41-113A108783C1 Q30415141-758F5F55-A484-47C0-AF03-FE15D9ADC30A Q31102336-65056488-8D1A-4D97-898F-A872FBF4E8D4 Q33842030-7E18B585-C151-4D0A-B930-5125CBE02E5D Q34057648-E91BB646-BEEF-4AB2-9287-CECA47F1293D Q34163308-179FD8C8-D77E-494E-9F05-D6101E6D7061 Q34668242-17FC5A06-5377-4981-AA0A-C4661677766C Q35941342-AB20EBE4-6206-4CFA-A11E-2B5167EBFBDD Q37023191-43739919-8F52-4F4B-A8CF-5BDCF8D5E8CF Q37264353-16FC35F5-02AB-41B7-856C-0EBAA8D4E366 Q37612207-DD98B9E7-8250-4369-B8C2-5878452BE976 Q37612977-4B26A992-C76A-4C27-8A16-5B093C37C84B Q37998436-F3B62C49-927C-4E65-90C0-B831E7DBD9FB Q38626867-8E19BFA7-4E75-4685-A0C2-2C7E7C115592 Q40079140-D25195A3-F943-4E90-939D-D4EA971C4C72 Q40087078-456F6A87-965B-406B-A7FA-B90C77B1DE0F Q40282138-67AEE95C-9CC2-4824-8531-129E05882120 Q40587151-FF800F33-19C8-479C-B8F6-3C88FF8E5B51 Q41299425-1BC874A3-3EBF-4667-86B1-79C482F13EF6 Q41772511-CE531E0A-E3C1-4E30-A1F6-42528FF1D016 Q42003543-9FF8B3EC-98D4-463D-884E-EA87614B9661 Q43521824-B8177DD5-0326-4E83-B651-F73441F3ADC6 Q43802648-1B55C93D-C54C-4903-B2BF-F47386E92B4C Q46471411-8046CA92-D4A9-4DF8-A956-845349DA1957 Q47853199-89429143-2EE2-4645-8F04-4809AFB80574 Q50523195-F4AD07ED-4564-4088-A498-BCE7F7E02CBD Q54252029-12555B9E-1A13-4767-91EB-C407BC97775B

P2860

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.

http://www.wikidata.org/entity/Q30389929

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Diversity of Escherichia coli ...... pain: second nationwide study.

@ast

Diversity of Escherichia coli ...... pain: second nationwide study.

@en

type

label

Diversity of Escherichia coli ...... pain: second nationwide study.

@ast

Diversity of Escherichia coli ...... pain: second nationwide study.

@en

prefLabel

Diversity of Escherichia coli ...... pain: second nationwide study.

@ast

Diversity of Escherichia coli ...... pain: second nationwide study.

@en

P1433

Q30389929-58878FF9-08A4-44DF-AAB0-E9667BBA71F6

P1476

Q30389929-EC2C3C6D-2611-449A-9E45-C6DAA2B81EF1

P2093

Q30389929-1ABCB47E-9B7D-48E5-B3CF-5934E6F87B49

Q30389929-2CA640C3-C300-4D74-BB65-A72EA6D862F2

Q30389929-A67A7408-524B-47B7-BF7E-1B50BDF776B0

Q30389929-A695C9CB-470E-4196-98B6-9EC3A3A41481

Q30389929-B9D8ACAC-A62C-42CF-8FF4-D88B90A4BD0A

Q30389929-FDB9C663-E2DC-4757-9692-86F847CD3B88

P2860

Q30389929-07D205CE-98A0-42C2-8CCC-0EF4E1C746AF

Q30389929-14BDADAA-B324-4139-9A28-6AEA2C67787D

Q30389929-1DFC1F0B-4EAC-44ED-B921-551581ED4D90

Q30389929-251A5D16-70F2-4E71-B1FF-DAA79C546C55

Q30389929-2DD01DB2-A260-4E81-889F-5BFDB27DD755

Q30389929-4FDF8768-4F7C-4B56-9D67-CF3116329518

Q30389929-546F1BA9-4E79-47AB-BE82-0BC3E680C47B

Q30389929-5980FC2B-A616-4BCC-97F5-0BB247683EF6

Q30389929-87DD64E3-BD4F-47C1-A16E-E0499164746F

Q30389929-95BB35ED-7E33-4E44-B6E3-06DDE7BE993C

P304

Q30389929-676E35EE-65CA-4737-A607-223C217A3799

P31

Q30389929-BDA8E2CF-68F4-41E1-8C3A-2292196E2C9E

P356

Q30389929-FBA7E236-1CF1-4E7A-8EB1-3DE894D76FAA

P407

Q30389929-7A141620-391E-4E65-AEFA-89CA78C30434

P433

Q30389929-53311571-8CD5-43B5-8938-2B60A32AA95E

P478

Q30389929-65B5F8BA-B349-4507-B2D0-BC45CF7A1B0D

P50

Q30389929-82E682A7-B619-4E4F-B53A-8692168F7BB2

Q30389929-CB63F30C-C7DF-4890-80FC-EAB213213D7B

P577

Q30389929-7B11EBE2-8AC9-4F60-A68C-85850B3EC9E2

P5875

Q30389929-9ACE8923-2ACA-43A1-BBE7-94591BC255DA

P698

Q30389929-921E7267-CB20-41B9-AB55-8038657005B3

P932

Q30389929-7C2C690B-B428-46E2-87F9-324C4869619F

P356

P1433

Journal of Clinical Microbiology

P1476

Diversity of Escherichia coli ...... pain: second nationwide study.

@en

P2093

Alvaro Pascual

http://www.w3.org/2001/XMLSchema#string

Jorge Calvo

http://www.w3.org/2001/XMLSchema#string

José R Hernández-Bello

http://www.w3.org/2001/XMLSchema#string

Luis Martínez-Martínez

http://www.w3.org/2001/XMLSchema#string

Miguel A Díaz

http://www.w3.org/2001/XMLSchema#string

Spanish Group for Nosocomial Infections (GEIH)

http://www.w3.org/2001/XMLSchema#string

P2860

The CTX-M beta-lactamase pandemic.

Extraintestinal pathogenic Escherichia coli O1:K1:H7/NM from human and avian origin: detection of clonal groups B2 ST95 and D ST59 with different host distribution.

Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions

Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting.

Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain.

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isola

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

P304

2840-2845

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.02147-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P50

Jesús Rodríguez-Baño

P577

2010-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44646049

http://www.w3.org/2001/XMLSchema#string

P698

20519460

http://www.w3.org/2001/XMLSchema#string

P932

2916592

http://www.w3.org/2001/XMLSchema#string